For more information: firstname.lastname@example.org; For access to the Aurora Test, please contact us.
Fertiga is a spin-off company from one of the global IVF leading centers, UZ Brussels in Belgium.
UZ Brussel has been pioneering in IVF, with the first ICSI baby worldwide born in 1992 from the Center of Reproductive Medicine of UZ Brussels.
Fertiga is the first provider worldwide on analysis of cumulus cells to improve live birth rates.
Our aim is to improve fertility treatments to give access to more couples and to reduce the overall burden of the treatment. We strive to have as many women as possible pregnant from the first attempt. Our motto is: one try, one child.
Prof. Dr. Johan Smitz, Chief Medical Officer
Prof Smitz – a medical doctor by training – is the head of the Follicle Biology (FOBI) group at the Free University of Brussels (VUB) and member of clinical diagnostics department at University Hospital of VUB (UZ Brussels). Johan has been involved for more than 10 years in the development of new diagnostic modalities to predict oocyte competence for pregnancy outcome in women undergoing in-vitro fertilization after hormone stimulation. This technology is a key component of Fertiga’s offering in the market.
Ir Elien Van Hecke, Chief Commercial Officer
Ms Van Hecke is a bioengineer by training and holds a master’s in business economics. She has seven years of experience in different marketing and sales roles both in Biotech (Innogenetics) and large diagnostic companies (Fujirebio/Roche). Elien decided to exit from Roche Belgium to start-up Fertiga in 2017.
Prof. Dr. André Rosenthal, Chief Executive Officer
Prof Rosenthal – molecular biologist by training – was member of the leadership group (2015-2017) of Roche Sequencing, a business unit headquartered in California. He was the sole founder and CEO of Signature Diagnostic, a cancer diagnostic company in Germany, which he sold to Roche in 2015. Andre has extensive experience in clinical and experimental cancer research, human genetics and genomics. From 1994 to 2001 he was the head of the German Human Genome Sequencing Project contributing the sequence of chromosome 21 in 2000. He joined Fertiga beginning of 2018.